Functional Blood Progenitor Markers in Developing Human Liver Progenitors.

Area of Science:

• Developmental Biology
• Stem Cell Biology
• Hepatology

Background:

• Early fetal liver development involves the co-maturation of hematopoietic and hepatic progenitors.
• Previous studies noted shared cell surface markers like CD34 and CD133 between these progenitor types.
• The precise roles of these shared markers in hepatoblast development remained unclear.

Purpose of the Study:

• To investigate the expression and function of hematopoietic markers in human hepatoblast development.
• To validate findings in both human embryonic stem cell models and primary human fetal liver samples.
• To elucidate the role of CD34, CD133, and GATA2 in regulating hepatic fate.

Main Methods:

• Utilized human embryonic stem cell (hESC) differentiation to generate hepatoblast-like cells.
• Analyzed cell surface marker expression (CD34, CD133) and transcription factor (GATA2) dynamics.
• Validated marker expression in human fetal liver tissues from the first and second trimesters.
• Performed gene knockdown experiments to assess functional roles.

Main Results:

• hESC-derived hepatoblast-like cells transiently express CD34, CD133, and GATA2, previously unassociated with hepatoblasts.
• Dynamic expression patterns of these markers were confirmed in human fetal liver samples.
• Gene knockdown revealed cell-autonomous functions of these markers in regulating hepatic fate.

Conclusions:

• Hematopoietic progenitor markers CD34, CD133, and GATA2 are integral to human hepatoblast development.
• These markers play significant, cell-autonomous roles in regulating the trajectory of liver progenitor cells.
• This study uncovers novel functions of fetal hematopoietic markers in the context of human liver progenitor biology.